PremiumCompany AnnouncementsP3 Health Partners Reports 2024 Financial Results P3 Health Partners backs FY25 revenue view $1.35B-$1.5B, consensus $1.4B P3 Health Partners reports Q4 EPS (36c) vs (22c) last year PremiumThe FlyP3 Health Partners price target lowered to 25c from 90c at TD Cowen P3 Health Partners Inc. Faces Nasdaq Delisting Risk Amid Bid Price Compliance Struggles P3 Health Partners Reports Increased Revenue Amidst Challenges PremiumThe FlyP3 Health Partners sees FY24 revenue $1.45B-$1.55B, consensus $1.53B P3 Health Partners reports Q2 EPS (15c), consensus (5c) P3 Health Partners, Innovaccer team to expand value-based care initiatives 
